IGF1 and hepatocellular carcinoma: AKT inhibitor MK2206, or AKT phosphorylation activator IGF-1, abolished the cell proliferation (a), migration (b), invasion (c) and apoptosis (d) of HCC cells which were transduced of ANXA11 vectors.